Assignee
AFFIBODY AB
SE·26 granted patents·17 pending applications·132 citations·filing 1999–2024
Top patents by PatentIndex Score
43 records- 0190US7993650B2Polypeptides having binding affinity for HER2AFFIBODY AB·Filed 2004·Granted Aug 9, 2011·33 cites·42 claims
- 0288US6831161B1Method of affinity separation and ligands for use thereinAFFIBODY AB·Filed 1999·Granted Dec 14, 2004·51 cites·10 claims
- 0386US6955877B1In vitro selection and optional identification of polypeptides using solid support carriersAFFIBODY AB·Filed 2000·Granted Oct 18, 2005·21 cites·11 claims
- 0484US9982022B2Binding polypeptides having a mutated scaffoldAFFIBODY AB·Filed 2014·Granted May 29, 2018·5 cites·16 claims
- 0582US8883120B2Polypeptides having affinity for HER2AFFIBODY AB·Filed 2013·Granted Nov 11, 2014·6 cites·22 claims
- 0679US7993848B2Staphylococcus protein A domain mutants that bind to TNF-αAFFIBODY AB·Filed 2006·Granted Aug 9, 2011·3 cites·42 claims
- 0776US2022169712A1Method for reducing the immune response to a biologically active proteinAFFIBODY AB·Filed 2022·Application pending·0 cites
- 0876US2025101074A1Il-17a-binding polypeptidesAFFIBODY AB·Filed 2024·Application pending·0 cites
- 0974US10556933B2Polypeptide libraries with a predetermined scaffoldAFFIBODY AB·Filed 2016·Granted Feb 11, 2020·1 cites·20 claims
- 1074US10323066B2Neonatal Fc receptor binding dimer and methods of useAFFIBODY AB·Filed 2015·Granted Jun 18, 2019·2 cites·23 claims
- 1174US10118949B2Compositions, methods and usesAFFIBODY AB·Filed 2014·Granted Nov 6, 2018·1 cites·20 claims
- 1271US9975943B2PolypeptidesAFFIBODY AB·Filed 2014·Granted May 22, 2018·2 cites·46 claims
- 1371US9745350B2HER3 binding polypeptidesAFFIBODY AB·Filed 2013·Granted Aug 29, 2017·2 cites·24 claims
- 1470US10155792B2Albumin binding polypeptideAFFIBODY AB·Filed 2013·Granted Dec 18, 2018·2 cites·24 claims
- 1569US10934335B2IL-17A-binding polypeptidesAFFIBODY AB·Filed 2016·Granted Mar 2, 2021·1 cites·19 claims
- 1668US2020291102A1Method for reducing the immune response to a biologically active proteinAFFIBODY AB·Filed 2020·Application pending·0 cites
- 1766US12221464B2Methods of treatment of IL-17A associated conditionsAFFIBODY AB·Filed 2021·Granted Feb 11, 2025·0 cites·32 claims
- 1866US9957330B2PolypeptidesAFFIBODY AB·Filed 2013·Granted May 1, 2018·1 cites·19 claims
- 1963US9745340B2Method for the separation of proteins containing an albumin-bindingAFFIBODY AB·Filed 2013·Granted Aug 29, 2017·1 cites·14 claims
- 2063US2018086822A1Method for reducing the immune response to a biologically active proteinAFFIBODY AB·Filed 2017·Application pending·0 cites
- 2160US2020199197A1PolypeptidesAFFIBODY AB·Filed 2020·Application pending·0 cites
- 2260US2017129944A9Method for reducing the immune response to a biologically active proteinAFFIBODY AB·Filed 2014·Application pending·0 cites
- 2358USRE49495EBinding polypeptides having a mutated scaffoldAFFIBODY AB·Filed 2014·Granted Apr 18, 2023·0 cites·18 claims
- 2458US2019031727A1Oral administrationAFFIBODY AB·Filed 2018·Application pending·0 cites
- 2558US2019375799A1PolypeptidesAFFIBODY AB·Filed 2019·Application pending·0 cites
- 2656US2024101605A1New polypeptideAFFIBODY AB·Filed 2021·Application pending·0 cites
- 2755US2024124533A1New her2-binding polypeptideAFFIBODY AB·Filed 2022·Application pending·0 cites
- 2855US2022411743A1New process of extracting proteinAFFIBODY AB·Filed 2020·Application pending·0 cites
- 2953US10562955B2PolypeptidesAFFIBODY AB·Filed 2017·Granted Feb 18, 2020·0 cites·47 claims
- 3052US10329331B2PolypeptidesAFFIBODY AB·Filed 2015·Granted Jun 25, 2019·0 cites·60 claims
- 3151US2016009767A9Oral administrationAFFIBODY AB·Filed 2013·Application pending·0 cites
- 3249US2006035265A1In vitro selection and optional indentification of polypeptides using solid support carriersAFFIBODY AB·Filed 2005·Application pending·0 cites
- 3349US2019284241A1Neonatal Fc Receptor Binding Dimer and Methods of UseAFFIBODY AB·Filed 2019·Application pending·0 cites
- 3447US10167322B2Engineered albumin binding polypeptideAFFIBODY AB·Filed 2014·Granted Jan 1, 2019·0 cites·19 claims
- 3545US2018230235A1PolypeptidesAFFIBODY AB·Filed 2018·Application pending·0 cites
- 3644US11505576B2Polypeptides based on a scaffoldAFFIBODY AB·Filed 2019·Granted Nov 22, 2022·0 cites·18 claims
- 3742US2018057551A1Alzheimer abeta peptide binding polypeptideAFFIBODY AB·Filed 2016·Application pending·0 cites
- 3838US10011641B2ABD binding polypeptideAFFIBODY AB·Filed 2013·Granted Jul 3, 2018·0 cites·15 claims
- 3938US2022389066A1PolypeptidesAFFIBODY AB·Filed 2020·Application pending·0 cites
- 4035US11155596B2PolypeptideAFFIBODY AB·Filed 2016·Granted Oct 26, 2021·0 cites·34 claims
- 4135US10633423B2IL-6-binding polypeptide complexAFFIBODY AB·Filed 2015·Granted Apr 28, 2020·0 cites·24 claims
- 4234US10669314B2PolypeptideAFFIBODY AB·Filed 2015·Granted Jun 2, 2020·0 cites·20 claims
- 4324US10364280B2PolypeptideAFFIBODY AB·Filed 2016·Granted Jul 30, 2019·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when AFFIBODY AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →